Waldorf Astoria, NYC
A continuous increase in demand for dental implant treatments as a result of growing consumer awareness, an ageing population, growing accessibility as well as greater product availability, has accelerated the demand for education in this field.
With its global symposium in particular, Nobel Biocare has established itself as a provider of top-level education. With more than 150 world-class speakers, more than 50 master classes and 40 hands-on courses for dentists and dental technicians, the Symposium is the implant dentistry event of the year.
“We are continuing the journey to innovation we started in 2010 with the first global symposium,” says Nobel Biocare president Hans Geiselhoringer. “We challenge ourselves every day to think about how we can be more successful in treating patients – this is the DNA of Nobel Biocare.”
The symposium was also the stage for the unveiling of several Nobel Biocare innovations, each designed to improve workflow efficiency and treatment outcomes. These included the On1 restorative concept, the nobelzygoma implant and the new nobeldesign CAD software. The range of creos regenerative solutions was also extended with the launch of creos xenogain xenogenic bone substitute. The event also marked the evolution of nobelprocera, with the introduction of the nobelprocera Crown – the first in a series of restorative options in a new high-translucency multilayered zirconia.
Many delegates also took the opportunity to take a tour of the nobelprocera production and services center in nearby Mahwah, New Jersey. Thought to be the largest dental CAD/CAM facility in the world, guests were given a rare chance to go behind the scenes and see the industrial production and extensive quality control procedures in action.
Attendees were also given an advance preview of forthcoming innovations such as the Trefoil concept for the edentulous mandible. Developed with some of the world’s leading clinicians, it is a truly innovative full-arch restoration on three implants with a revolutionary prosthetic framework. The concept will allow even more patients to benefit from a fixed implant restoration and feedback from early testers has been excellent.
